Mahdi Hatamipour Selected Research

Mahdi Hatamipour Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 07/2013
5	Melanoma (Melanoma, Malignant) 10/2023 - 01/2019
3	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2017
3	Atherosclerosis 01/2021 - 10/2018
3	Carcinoma (Carcinomatosis) 02/2020 - 01/2019
2	COVID-19 01/2023 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 12/2018 - 02/2018
2	Dyslipidemias (Dyslipidemia) 10/2018 - 05/2015
1	Leishmaniasis 02/2021
1	Enterobiasis 01/2021
1	Insulin Resistance 01/2021
1	Cutaneous Leishmaniasis 12/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2019
1	Body Weight (Weight, Body) 01/2019
1	Parasitic Diseases (Parasitic Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Fatty Liver 09/2016
1	Non-alcoholic Fatty Liver Disease 09/2016

Drug/Important Bio-Agent (IBA)

6	Liposomes (Liposome)IBA 12/2021 - 10/2018
5	VaccinesIBA 01/2023 - 01/2017
5	CurcuminIBA 03/2022 - 09/2016
5	Peptides (Polypeptides)IBA 08/2020 - 01/2017
3	DiarylheptanoidsIBA 03/2022 - 02/2018
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2023
2	LipidsIBA 02/2021 - 01/2019
2	liposomal doxorubicin (Doxil)FDA Link 02/2020 - 01/2019
2	galbanic acidIBA 02/2020 - 01/2019
2	Niclosamide FDA Link 01/2020 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 05/2015
2	CholesterolIBA 01/2019 - 10/2018
1	Cancer VaccinesIBA 10/2023
1	Lipid NanoparticlesIBA 01/2023
1	demethoxycurcuminIBA 03/2022
1	AntioxidantsIBA 03/2022
1	Coloring Agents (Dyes)IBA 03/2022
1	LigandsIBA 12/2021
1	Silybin (Lagosa)IBA 12/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 02/2021
1	AntigensIBA 02/2021
1	PhosphatidylserinesIBA 01/2021
1	PhytosomesIBA 01/2021
1	pyrvinium (Vankin)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	CPG-oligonucleotideIBA 08/2020
1	NanovaccinesIBA 08/2020
1	Monoclonal AntibodiesIBA 08/2020
1	Combined VaccinesIBA 08/2020
1	Therapeutic UsesIBA 08/2020
1	AntibodiesIBA 02/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2019
1	Advanced Glycation End ProductsIBA 11/2019
1	Free RadicalsIBA 11/2019
1	Methotrexate (Mexate)FDA LinkGeneric 10/2019
1	Imiquimod (Aldara)FDA LinkGeneric 10/2019
1	SesquiterpenesIBA 01/2019
1	DisaccharidesIBA 01/2019
1	TrehaloseIBA 01/2019
1	1-dodecylpyridoxal (PLD)IBA 01/2019
1	coumarinIBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 12/2018
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 12/2018
1	Adenosine Monophosphate (AMP)IBA 12/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2018
1	Lipid Bilayers (Lipid Bilayer)IBA 10/2018
1	CollagenIBA 10/2018
1	LDL Receptors (LDL Receptor)IBA 10/2018
1	Scarlet Red (Sudan IV)IBA 10/2018
1	PhytochemicalsIBA 02/2018
1	bisdemethoxycurcuminIBA 02/2018
1	PolyphenolsIBA 09/2016
1	ApolipoproteinsIBA 05/2015
1	taxodioneIBA 07/2013
1	ferruginolIBA 07/2013
1	6-hydroxysalvinoloneIBA 07/2013

Therapy/Procedure

5	Therapeutics 01/2021 - 01/2019
2	Immunotherapy 02/2020 - 12/2018
1	Drug Therapy (Chemotherapy) 02/2020
1	Radiotherapy 12/2018